NEW YORK (GenomeWeb) — Laboratory Corporation of America announced today that it has agreed to acquire the operating assets of women's health laboratory Pathology Inc.

The terms of the deal were undisclosed.

The deal encompasses all of Pathology's operating assets, including its patient service centers, LabCorp said in a statement. The Torrance, California-based Pathology provides expertise in reproductive FDA donor testing, as well as anatomic, molecular, and digital pathology services, LabCorp added.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.